You have 9 free searches left this month | for more free features.

11 beta-Hydroxysteroid dehydrogenase1 inhibitor

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 2 Diabetes in Obese, Obesity, Type2Diabetes Trial in San Diego (SPI-62, Cortisone-d8)

Completed
  • Type 2 Diabetes Mellitus in Obese
  • +2 more
  • Chula Vista, California
    ProSciento
Jan 26, 2023

Iatrogenic Cushing's Disease Trial in Oxford (AZD4017 and prednisolone, Placebo Oral Tablet and prednisolone)

Completed
  • Iatrogenic Cushing's Disease
  • AZD4017 and prednisolone
  • Placebo Oral Tablet and prednisolone
  • Oxford, United Kingdom
    University of Oxford
May 12, 2021

Idiopathic Intracranial Hypertension Trial in Birmingham (AZD4017, Placebo)

Completed
  • Idiopathic Intracranial Hypertension
  • Birmingham, West Midlands, United Kingdom
    University Hospital Birmingham (Queen Elizabeth Hospital)
Sep 28, 2021

Unipolar Depression Trial in Marburg (Enoxolone)

Recruiting
  • Unipolar Depression
  • Marburg, Hessen, Germany
    Clinic for Psychiatry and Psychotherapy
Oct 3, 2022

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

Not yet recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 23, 2023

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia

Not yet recruiting
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Biospecimen Collection
  • +12 more
  • (no location specified)
Mar 8, 2023

Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

Recruiting
  • Advanced Solid Tumor
  • +24 more
  • MDNA11 Monotherapy
  • MDNA11 in combination with checkpoint inhibitor
  • Santa Monica, California
  • +7 more
Nov 1, 2022

Mantle Cell Lymphoma Trial in United States (Acalabrutinib, Bortezomib, Cyclophosphamide)

Recruiting
  • Mantle Cell Lymphoma
  • New Orleans, Louisiana
  • +5 more
Dec 13, 2022

Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)

Recruiting
  • Refractory Cancer
  • +10 more
  • Aurora, Colorado
  • +7 more
Dec 31, 2022

MDD, MDD, Cognitive Impairment Trial in Australia (Xanamem™, Placebo)

Recruiting
  • Major Depressive Disorder
  • +2 more
  • Canberra, Australian Capital Territory, Australia
  • +10 more
Dec 11, 2022

Blastoid Variant Mantle Cell Lymphoma, CD20 Positive, Mantle Cell Lymphoma Trial in Houston (drug, other, biological)

Active, not recruiting
  • Blastoid Variant Mantle Cell Lymphoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Trial in Israel, United States (Blinatumomab,

Recruiting
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Blinatumomab
  • +10 more
  • Anchorage, Alaska
  • +152 more
Aug 11, 2022

Cortisol Metabolism in Familial Partial Lipodystrophy Type 2

Recruiting
  • Familial Partial Lipodystrophy Type 2
  • Biopsy
  • Lille, France
    Hop Claude Huriez
Jun 20, 2022

Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia Trial in Worldwide (radiation, biological, drug)

Suspended
  • Down Syndrome
  • Recurrent B Acute Lymphoblastic Leukemia
  • 3-Dimensional Conformal Radiation Therapy
  • +13 more
  • Birmingham, Alabama
  • +202 more
Jan 17, 2023

Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Vienna, Austria
  • +3 more
Jun 8, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Portland (drug, device, biological)

Completed
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
May 21, 2020

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Anti-TGF-beta Monoclonal Antibody SAR-439459
  • Cemiplimab
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2022

Steroid Metabolism in Obese and Non-Obese Pediatric Patients

Completed
  • Pediatric Obesity
  • Asthma in Children
  • Durham, North Carolina
    Duke University Hospital
Jun 30, 2022

Acute Heart Failure Trial

Not yet recruiting
  • Acute Heart Failure
    • (no location specified)
    May 9, 2023

    Pancreatic Lipomatosis Trial in Chandigarh (Dapagliflozin 10mg Tab)

    Completed
    • Pancreatic Lipomatosis
    • Dapagliflozin 10mg Tab
    • Chandigarh, India
      Deptt of Endocrinology
    Apr 6, 2023

    Heart Failure Trial in Shatin (Dapagliflozin)

    Not yet recruiting
    • Heart Failure
    • Shatin, Hong Kong
      The Chinese University of Hong Kong
    Feb 24, 2023

    Diabetes, Cellular Senescence, Sodium-Glucose Transporter 2 Inhibitors Trial in Seoul (SGLT2 inhibitor, Glimepiride)

    Not yet recruiting
    • Diabetes Mellitus
    • +2 more
    • Seoul, Korea, Republic of
      Yonsei University College of Medicine
    Aug 1, 2023

    Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (BCX9930 monotherapy, Placebo)

    Active, not recruiting
    • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • BCX9930 monotherapy
    • Placebo
    • Ampang, Malaysia
    • +3 more
    Dec 15, 2022

    Bacterial Infections Trial in Adelaide (QPX2015, Placebo oral capsule)

    Completed
    • Bacterial Infections
    • Adelaide, South Australia, Australia
      CMAX
    Oct 6, 2022